Clinical Trial Update: The Effects of Tirofiban in Diabetic Patients Undergoing Elective Percutaneous Coronary Intervention [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update assessing the effects of tirofiban in diabetic patients undergoing elective percutaneous coronary intervention for coronary arte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Diabetes Mellitus

Drugs mentioned

• Aggrastat (tirofiban)

Snippet

Sponsor: Jordan Hospital | Conditions: Coronary Artery Disease | Phase 4 | Status: UNKNOWN